PYXS

Pyxis Oncology Inc
1.57
-0.02 (-1.26%)
Company Name Stock Ticker Symbol Market Type
Pyxis Oncology Inc PYXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.26% 1.57 16:02:21
Open Price Low Price High Price Close Price Prev Close
1.61 1.54 1.632 1.57 1.59
more quote information »

Recent News

Date Time Source Heading
12/01/202207:04EDGARCurrent Report Filing (8-k)
11/15/202206:51EDGARNotice of Effectiveness (effect)
11/01/202207:32EDGARQuarterly Report (10-q)
11/01/202207:15EDGARCurrent Report Filing (8-k)
10/07/202216:32EDGARCurrent Report Filing (8-k)
9/30/202217:00GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
8/18/202222:15TRMNLifeSci Capital Remains a Buy on Pyxis Oncology (PYXS)
8/15/202217:45EDGARStatement of Changes in Beneficial Ownership (4)
8/15/202217:32EDGARInitial Statement of Beneficial Ownership (3)
8/15/202207:23EDGARQuarterly Report (10-q)
8/15/202207:17EDGARCurrent Report Filing (8-k)
8/15/202207:00GLOBEPyxis Oncology Reports Financial Results for the Second..
8/09/202216:35EDGARInitial Statement of Beneficial Ownership (3)
8/09/202216:14EDGARCurrent Report Filing (8-k)
7/12/202206:45GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
7/01/202217:07EDGARSecurities Registration: Employee Benefit Plan (s-8)
6/28/202206:35GLOBEPyxis Oncology to Present at H.C. Wainwright Preclinical..
6/14/202216:31EDGARCurrent Report Filing (8-k)
5/23/202206:16EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
5/19/202206:35GLOBEPyxis Oncology Announces Presentations at Upcoming Investor..
5/15/202210:16TRMNPyxis Oncology (PYXS) Gets a Buy Rating from William Blair
5/13/202208:20EDGARQuarterly Report (10-q)
5/13/202208:13EDGARCurrent Report Filing (8-k)
5/13/202208:03GLOBEPyxis Oncology Reports Financial Results for the Quarter..
4/28/202216:41EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/27/202206:35GLOBEPyxis Oncology to Participate in Fireside Chat at BofA..
4/25/202212:12EDGARStatement of Changes in Beneficial Ownership (4)
4/14/202217:11EDGARCurrent Report Filing (8-k)
4/13/202206:35GLOBEPyxis Oncology Announces Leadership Changes
4/08/202213:05GLOBEPyxis Oncology Announces Preclinical Data on Anti-Siglec-15..
4/04/202216:18EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202216:18EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
3/30/202210:34TRMNJefferies Thinks Pyxis Oncology’s Stock is Going to Recover
3/29/202212:52SEEKPyxis Oncology to pay $10M upfront to license Biosion's..
3/29/202211:00PRNUSBiosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology
3/29/202207:38EDGARAnnual Report (10-k)
3/29/202207:32EDGARCurrent Report Filing (8-k)
3/29/202207:12SEEKPyxis Oncology GAAP EPS of -$8.95 misses by $5.88
3/29/202206:35GLOBEPyxis Oncology Provides Corporate and Financial Update
3/22/202206:35GLOBEPyxis Oncology to Host Corporate Update Conference Call and..
2/14/202208:52EDGARStatement of Ownership (sc 13g)